Cargando…
State policy influence on the early diffusion of buprenorphine in community treatment programs
BACKGROUND: Buprenorphine was approved for use in the treatment of opioid dependence in 2002, but its diffusion into everyday clinical practice in community-based treatment programs has been slow. This study examines the net impact of efforts by state agencies, including provision of Medicaid covera...
Autores principales: | Ducharme, Lori J, Abraham, Amanda J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464589/ https://www.ncbi.nlm.nih.gov/pubmed/18570665 http://dx.doi.org/10.1186/1747-597X-3-17 |
Ejemplares similares
-
Community Treatment Programs Take Up Buprenorphine
por: Casadonte, Paul P., et al.
Publicado: (2004) -
Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
por: Stein, Bradley D., et al.
Publicado: (2023) -
Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs
por: Keshwani, Shailina, et al.
Publicado: (2022) -
Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
por: Furo, Hiroko, et al.
Publicado: (2021) -
Factors Influencing Buprenorphine Prescribing among Physicians in New York State
por: Marino, Leslie A., et al.
Publicado: (2019)